Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hanferon + Ribavirin in Genotype 1 Hepatitis C
NCT01194037Phase 2Completed
- Sponsor
- HanAll Biopharma
- Start
- Jun 2011
- Primary completion
- Nov 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Interferon alfa-2b vaginal effervescent tablet in hepatitis C virus infection, sponsored by HanAll Biopharma. Started Jun 2011; status: completed.
02
Drugs
Interferon alfa-2b vaginal effervescent tablet
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01194037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194037.